SCHEMBL29368656

SCHEMBL29368656

CCC(=O)c1cc(C)ccc1O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK2A1 P68400 1/20 0.62
RAB9A P51151 4/20 0.57
KDM4E B2RXH2 4/20 0.57
MEN1 O00255 4/20 0.57
KMT2A Q03164 4/20 0.57
LMNA P02545 3/20 0.57
POLB P06746 2/20 0.57
HSP90AB1 P08238 1/20 0.53
MAPT P10636 3/20 0.53
HPGD P15428 3/20 0.53
HTT P42858 3/20 0.53
NPC1 O15118 2/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
NPSR1 Q6W5P4 2/20 0.53
TSHR P16473 1/20 0.53
HSD17B10 Q99714 1/20 0.53
HMGCR P04035 1/20 0.50
PLA2G1B P04054 1/20 0.49
XBP1 P17861 1/20 0.49
ALOX12 P18054 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1305878 1.00 CSNK2A1 (0.62) CSNK2A1RAB9AKDM4EMEN1KMT2A
SCHEMBL8465257 0.85 RAB9A (0.59) CSNK2A1RAB9AKDM4EMEN1KMT2A
SCHEMBL11074148 0.85 HPGD (0.61) CSNK2A1RAB9AKDM4EMEN1KMT2A
SCHEMBL9639259 0.84 HSP90AB1 (0.69) CSNK2A1RAB9AKDM4EMEN1KMT2A
SCHEMBL3233653 0.82 CSNK2A1 (0.60) CSNK2A1RAB9AKDM4EMEN1KMT2A
SCHEMBL11213739 0.82 CSNK2A1 (0.60) CSNK2A1RAB9AKDM4EMEN1KMT2A
SCHEMBL31602938 0.82 CSNK2A1 (0.60) CSNK2A1RAB9AKDM4EMEN1KMT2A
SCHEMBL8712689 0.82 CSNK2A1 (0.55) CSNK2A1RAB9AKDM4EMEN1KMT2A
SCHEMBL29457562 0.82 HSP90AB1 (0.71) MEN1KMT2APOLBHSP90AB1HTT
SCHEMBL31693367 0.82 MEN1 (0.65) RAB9AKDM4EMEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114008012-B Compounds for the treatment of neuromuscular disorders NMD制药股份公司 2025-02-25 CN disclosed
CN-114502704-A Enol ether pro-fragrances 弗门尼舍有限公司 2022-05-13 CN disclosed
EP-3986852-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD Pharma A/S (DK) 2022-04-27 EP disclosed
CN-114008012-A Compounds for the treatment of neuromuscular disorders NMD制药股份公司 2022-02-01 CN disclosed